The average one-year price target for Century Therapeutics (NasdaqCM:IPSC) has been revised to $4.20 / share. This is an increase of 10.75% from the prior estimate of $3.79 dated January 11, 2026. The ...
Century Therapeutics Inc. (NASDAQ:IPSC) is one of the best fast growing penny stocks to buy according to analysts. On January ...
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Century ...
Zacks Investment Research on MSN
Century Therapeutics (IPSC) upgraded to strong buy: Here's what you should know
Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results